1. Home
  2. ALMU vs ALT Comparison

ALMU vs ALT Comparison

Compare ALMU & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMU
  • ALT
  • Stock Information
  • Founded
  • ALMU 2019
  • ALT 1997
  • Country
  • ALMU United States
  • ALT United States
  • Employees
  • ALMU N/A
  • ALT N/A
  • Industry
  • ALMU Semiconductors
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALMU Technology
  • ALT Health Care
  • Exchange
  • ALMU Nasdaq
  • ALT Nasdaq
  • Market Cap
  • ALMU 314.8M
  • ALT 333.6M
  • IPO Year
  • ALMU N/A
  • ALT N/A
  • Fundamental
  • Price
  • ALMU $17.58
  • ALT $3.93
  • Analyst Decision
  • ALMU Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • ALMU 2
  • ALT 6
  • Target Price
  • ALMU $25.50
  • ALT $17.40
  • AVG Volume (30 Days)
  • ALMU 470.3K
  • ALT 3.0M
  • Earning Date
  • ALMU 11-07-2025
  • ALT 11-11-2025
  • Dividend Yield
  • ALMU N/A
  • ALT N/A
  • EPS Growth
  • ALMU N/A
  • ALT N/A
  • EPS
  • ALMU N/A
  • ALT N/A
  • Revenue
  • ALMU $4,665,000.00
  • ALT $20,000.00
  • Revenue This Year
  • ALMU $19.59
  • ALT N/A
  • Revenue Next Year
  • ALMU $98.73
  • ALT N/A
  • P/E Ratio
  • ALMU N/A
  • ALT N/A
  • Revenue Growth
  • ALMU 407.62
  • ALT N/A
  • 52 Week Low
  • ALMU $2.52
  • ALT $2.90
  • 52 Week High
  • ALMU $25.88
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • ALMU 48.88
  • ALT 52.80
  • Support Level
  • ALMU $17.03
  • ALT $3.85
  • Resistance Level
  • ALMU $19.28
  • ALT $4.06
  • Average True Range (ATR)
  • ALMU 1.74
  • ALT 0.20
  • MACD
  • ALMU 0.10
  • ALT 0.02
  • Stochastic Oscillator
  • ALMU 36.34
  • ALT 57.35

About ALMU Aeluma Inc. Common Stock

Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: